Jacobs Levy Equity Management Inc. lifted its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 116.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 192,255 shares of the company's stock after acquiring an additional 103,491 shares during the period. Jacobs Levy Equity Management Inc. owned 0.47% of Phibro Animal Health worth $4,330,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in PAHC. Brandes Investment Partners LP lifted its holdings in Phibro Animal Health by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company's stock worth $40,521,000 after purchasing an additional 29,071 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Phibro Animal Health by 5.7% in the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company's stock worth $13,005,000 after buying an additional 42,086 shares in the last quarter. Acadian Asset Management LLC boosted its position in shares of Phibro Animal Health by 6.3% during the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company's stock worth $12,027,000 after acquiring an additional 42,299 shares during the last quarter. Dana Investment Advisors Inc. increased its holdings in Phibro Animal Health by 17.2% in the 2nd quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company's stock valued at $8,619,000 after acquiring an additional 75,546 shares during the last quarter. Finally, American Century Companies Inc. lifted its stake in Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company's stock worth $5,822,000 after purchasing an additional 189,068 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on PAHC. Barclays raised their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a research report on Tuesday, November 12th. Bank of America lifted their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the stock an "underperform" rating in a research note on Friday, August 30th. StockNews.com downgraded Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research report on Friday. Finally, JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a "neutral" rating and a $22.00 price target on the stock. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Phibro Animal Health presently has a consensus rating of "Hold" and a consensus target price of $16.50.
View Our Latest Research Report on Phibro Animal Health
Phibro Animal Health Trading Up 1.3 %
PAHC stock traded up $0.29 during midday trading on Friday, reaching $23.21. 85,607 shares of the company traded hands, compared to its average volume of 187,782. The firm has a market capitalization of $940.01 million, a price-to-earnings ratio of 53.98, a P/E/G ratio of 0.61 and a beta of 0.51. Phibro Animal Health Co. has a 52-week low of $10.03 and a 52-week high of $25.98. The business has a 50 day moving average of $23.44 and a 200-day moving average of $20.38. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23.
Phibro Animal Health Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health's dividend payout ratio (DPR) is 111.63%.
Phibro Animal Health Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
